Portage biotech completes monetization of intensity therapeutics (ints) shares

Company generated approximately $2.8m of non-dilutive funding to extend cash runway company generated approximately $2.8m of non-dilutive funding to extend cash runway
ATON Ratings Summary
ATON Quant Ranking